Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort

INTRODUCTION: Several clinical studies have reported the efficacy of favipiravir in reducing viral load and shortening the duration of symptoms. However, the viability of SARS-CoV-2 in the context of favipiravir therapy and the potential for resistance development is unclear. METHODS: We sequenced S...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Chemother
Hlavní autoři: Suzuki, Masahiro, Imai, Takumi, Sakurai, Aki, Komoto, Satoshi, Ide, Tomihiko, Lim, Chang Kweng, Shintani, Ayumi, Doi, Yohei, Murata, Takayuki
Médium: Artigo
Jazyk:Inglês
Vydáno: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196299/
https://ncbi.nlm.nih.gov/pubmed/34176716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2021.06.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky